Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab.
Mult Scler Relat Disord. 2022 Jan;57:103382. doi: 10.1016/j.msard.2021.103382. Epub 2021 Nov 9.
Mult Scler Relat Disord. 2022.
PMID: 35158475
Free PMC article.
No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS).
Kister I, Oh C, Douglas EA, Bacon TE, O'Shea IL, Parrotta EH, Bouley A, Lathi E, Katz J.
Kister I, et al. Among authors: o shea il.
Neurol Clin Pract. 2023 Oct;13(5):e200185. doi: 10.1212/CPJ.0000000000200185. Epub 2023 Sep 5.
Neurol Clin Pract. 2023.
PMID: 37674871
Free PMC article.
Item in Clipboard
Cite
Cite